These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18607017)

  • 21. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.
    Marzuillo C; De Giusti M; Tufi D; Giordano A; Del Cimmuto A; Quattrucci S; Mancini C; Villari P
    Infect Control Hosp Epidemiol; 2009 Aug; 30(8):753-8. PubMed ID: 19583515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation prioritization tool: revision, adaptation and application.
    Jeanes A; Macrae B; Ashby J
    Br J Nurs; 2011 May 13-26; 20(9):540-4. PubMed ID: 21647013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical aspects in infection control.
    Wagenvoort JH; Gelissen LL; Timpert H
    Infect Control Hosp Epidemiol; 1997 May; 18(5):304-5. PubMed ID: 9154470
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
    Jones AM; Webb AK
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):66-72. PubMed ID: 12906328
    [No Abstract]   [Full Text] [Related]  

  • 25. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
    Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
    BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of cystic fibrosis patients with multi-drug resistant Gram-negative rods.
    Vonberg RP; Wolter A; Ziesing S; Gastmeier P
    Int J Hyg Environ Health; 2006 Jul; 209(4):333-6. PubMed ID: 16679060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorder: good for cystic fibrosis (CF)?
    Chotirmall SH; Flynn MG; Kernekamp C; McElvaney NG
    Pediatr Pulmonol; 2009 Mar; 44(3):300-1. PubMed ID: 19206183
    [No Abstract]   [Full Text] [Related]  

  • 29. Are strict isolation policies based on susceptibility testing actually effective in the prevention of the nosocomial spread of multi-drug-resistant gram-negative rods?
    Ohmagari N; Kurai H; Yamagishi Y; Mikamo H
    Am J Infect Control; 2014 Jul; 42(7):739-43. PubMed ID: 24969125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitals should do the sick no harm. 12. Controlling infection by isolation - 2.
    Stronge JL; Meers PD
    Nurs Times; 1980 Dec 18-25; 76(51):suppl 1-4. PubMed ID: 6906671
    [No Abstract]   [Full Text] [Related]  

  • 31. Burkholderia cepacia: another twist and a further threat.
    Webb AK; Govan JR
    Thorax; 1998 May; 53(5):333-4. PubMed ID: 9708220
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications.
    Walters S; Smith EG
    Lancet; 1993 Jul; 342(8862):3-4. PubMed ID: 7686240
    [No Abstract]   [Full Text] [Related]  

  • 33. The psychological impact of isolation.
    Madeo M
    Nurs Times; 2003 Feb 18-24; 99(7):54-5. PubMed ID: 12655756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operation clean-up. Theory and practice of isolation nursing.
    Wilson J
    Nurs Stand; 1992 Jan 15-21; 6(17):30-1. PubMed ID: 1540506
    [No Abstract]   [Full Text] [Related]  

  • 35. Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei.
    Wood ME; Stockwell RE; Johnson GR; Ramsay KA; Sherrard LJ; Kidd TJ; Cheney J; Ballard EL; O'Rourke P; Jabbour N; Wainwright CE; Knibbs LD; Sly PD; Morawska L; Bell SC
    Thorax; 2019 Jan; 74(1):87-90. PubMed ID: 29627800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance fighters.
    Leach E
    Nurs Times; 1999 Sep 22-28; 95(38):18. PubMed ID: 10734889
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of Contact Isolation Precautions on Multi-Drug Resistant Acinetobacter baumannii in the Pediatric Intensive Care Unit.
    Tawney A; Semproch L; Lephart P; Valentine K; Thomas R; Asmar BI; Chopra T; McGrath EJ
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1108-10. PubMed ID: 26047364
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
    Vonberg RP; Wolter A; Chaberny IF; Kola A; Ziesing S; Suerbaum S; Gastmeier P
    Int J Hyg Environ Health; 2008 Jul; 211(3-4):251-7. PubMed ID: 17980660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of infectious cystic fibrosis patients: results of a systematic review.
    Vonberg RP; Gastmeier P
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):401-9. PubMed ID: 15865277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported outcome studies in hospitalized patients isolated due to multi-drug-resistant organisms: how representative are they and who can be included in respective studies?
    Wessels C; Kugler C; Mattner F
    J Hosp Infect; 2016 Sep; 94(1):52-3. PubMed ID: 27262907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.